Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease

Hillel Yaffe Medical Center500 enrolled

Overview

The proposed work is based on the detection of a novel molecule for sensitivity to oxidative stress in humans in venous blood

Since alterations in mitochondrial functions in platelets and lymphocytes have been detected in Parkinson's disease we plan to monitor the metabolism a a new molecule (LTG) in the blood samples of Parkinson's disease patients and compare them to controls. We shall use 10 cc of venous blood and analyze serum, white blood cells and platelets. We shall not extract nor use DNA.The main purpose is to develop a marker for Parkinson's disease in venous blood.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Parkinson's Disease Oxidative Stress

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Parkinson's disease Healthy control - Exclusion Criteria: None -

Locations (1)

Hillel Yaffe Medical Center

Hadera, Israel

RECRUITING

Central Contacts

Rivka Inzelberg, MD

CONTACT

+972-4-6304607 inzelberg@hy.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.